Rchr
J-GLOBAL ID:200901045066730583   Update date: Nov. 15, 2024

Koie Takuya

コイエ タクヤ | Koie Takuya
Affiliation and department:
Job title: Peofwssor
Research field  (1): Urology
Research keywords  (8): 前立腺癌 ,  膀胱癌 ,  回腸新膀胱 ,  内視鏡下小切開手術 ,  PLES ,  ileal neobladder ,  prostate cancer ,  bladder cancer
Research theme for competitive and other funds  (14):
  • 2017 - 2020 Ghrelin and butyrylcholinesterase levels may predict the progression of muscle-invasive bladder cancer
  • 2015 - 2020 Practical application of glycan-targeted biomarker to prevent over-diagnosis and over-treatment of prostate cancer
  • 2015 - 2018 Development of predictive biomarker for kidney transplant disorder by comprehensive structural analysis on serum glycan
  • 2012 - 2015 A new glyco-biomarker for comprehensive evaluation of malignant potential in prostate cancer
  • 2010 - 2015 Development of glycan-targetted assay system for diagnosis of prostate cancer
Show all
Papers (323):
  • Yuki Yokoyama, Makoto Kawase, Shin Ebara, Tomoyuki Tatenuma, Takeshi Sasaki, Yoshinori Ikehata, Akinori Nakayama, Masahiro Toide, Tatsuaki Yoneda, Kazushige Sakaguchi, et al. Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group). International urology and nephrology. 2024
  • Taku Naiki, Kiyoshi Takahara, Hiromitsu Watanabe, Keita Nakane, Yosuke Sugiyama, Takuya Koie, Ryoichi Shiroki, Hideaki Miyake, Takahiro Yasui. The prognostic superiority of second-generation androgen receptor signaling inhibitor in patients with non-metastatic castration-resistant prostate cancer. Japanese journal of clinical oncology. 2024
  • 飯沼 光司, 山田 豊博, 富岡 莉紗, 並木 早苗, 杉野 文哉, 熊田 直孝, 竹内 慎一, 川瀬 真, 中井 千愛, 高井 学, et al. 進行性腎癌に対しニボルマブ+イピリムマブ併用療法,カボザンチニブ投与後にcytoreductive nephrectomyを施行した1例. 腎癌研究会会報. 2024. 54. 111-111
  • Naotaka Kumada, Koji Iinuma, Yasuaki Kubota, Kimiaki Takagi, Masahiro Nakano, Takashi Ishida, Shigeaki Yokoi, Fumiya Sugino, Makoto Kawase, Shinichi Takeuchi, et al. Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study. Diseases (Basel, Switzerland). 2024. 12. 6
  • Masayuki Tomioka, Keita Nakane, Makoto Kawase, Koji Iinuma, Daiki Kato, Kota Kawase, Tomoki Taniguchi, Yuki Tobisawa, Fumiya Sugino, Tetsuro Kaga, et al. Discrepancy in the Location of Prostate Cancer Indicated on Biparametric Magnetic Resonance Imaging and Pathologically Diagnosed Using Surgical Specimens. Current oncology (Toronto, Ont.). 2024. 31. 5. 2846-2855
more...
MISC (328):
  • 飯沼 光司, 加藤 卓, 仲野 正博, 加藤 大貴, 高井 学, 前川 由佳, 中根 慶太, 水谷 晃輔, 土屋 朋大, 伊藤 政也, et al. 限局性前立腺癌に対する密封小線源療法後の下部尿路症状の変化. 日本泌尿器科学会総会. 2020. 108回. 490-490
  • 中根 慶太, 飯沼 光司, 高井 学, 加藤 大貴, 古家 琢也. 【今だからこそ考える限局性前立腺癌に対する治療】ロボット手術. 泌尿器外科. 2020. 33. 11. 1391-1396
  • 飯沼 光司, 田口 朱美, 中西 恵美子, 樋口 貴則, 柴田 和之, 大森 智泰, 細江 詩乃, 今井 和美, 加藤 大貴, 西野 好則, et al. 泌尿器科常勤医不在の僻地病院での排尿自立指導料算定の取り組み. 日本排尿機能学会誌. 2020. 31. 1. 217-217
  • Takuya Koie, Keita Nakane, Koji Iinuma. Editorial Comment from Dr Koie et al. to Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy. International Journal of Urology. 2020. 27. 7. 623
  • Hirotake Kodama, Takuya Koie, Masaaki Oikawa, Takuma Narita, Toshikazu Tanaka, Daisuke Noro, Hiromichi Iwamura, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, et al. Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy. International urology and nephrology. 2020. 52. 4. 671-679
more...
Professional career (1):
  • (BLANK)
Association Membership(s) (6):
THE JAPANESE SOCIETY FOR DIALYSIS THERAPY ,  JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  Japanese society of Minimum Incision Endoscopic Urological Surgery ,  JAPANESE SOCIETY OF ENDOUROLOGY ,  American Urological Association ,  日本泌尿器科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page